The pharmacokinetics of the β2-adrenoceptor agonist, tulobuterol, in Beagle dogs following transdermal and intravenous administration

J. H. Kim, T. H. Kim, H. J. Park, Y. J. Choi, J. H. Kang, K. H. Song, T. S. Koo, Kyoung Won Seo

Research output: Contribution to journalArticle

Abstract

Tulobuterol is a β2-adrenergic agonist that was the first bronchodilator approved as a transdermal patch for humans. Previous studies have examined the pharmacokinetics of tulobuterol in humans but not in the veterinary species. In this study, the pharmacokinetics of tulobuterol was examined in healthy Beagle dogs after transdermal and intravenous administration. The Cmax was 2.09 ng/mL at 16.0 h for a 0.2 mg/kg patch and 4.85 ng/mL at 13.6 h for a 0.4 mg/kg patch. The effective blood level in humans is 1-3 ng/mL, a concentration achieved using the 0.2 mg/kg patch in dogs. In conclusion, application of a 0.2 mg/kg tulobuterol patch to healthy dogs led to an apparently effective blood concentration for 24 h.

Original languageEnglish (US)
Pages (from-to)90-92
Number of pages3
JournalVeterinary Journal
Volume208
DOIs
StatePublished - Feb 1 2016
Externally publishedYes

Fingerprint

Cutaneous Administration
adrenergic receptors
Beagle
intravenous injection
Intravenous Administration
Adrenergic Receptors
agonists
pharmacokinetics
Pharmacokinetics
Dogs
dogs
bronchodilators
adrenergic agonists
blood
Transdermal Patch
Adrenergic Agonists
Bronchodilator Agents
tulobuterol

Keywords

  • Canine
  • Pharmacokinetics
  • Transdermal patch
  • Tulobuterol
  • β-adrenoceptor agonist

ASJC Scopus subject areas

  • Animal Science and Zoology
  • veterinary(all)

Cite this

The pharmacokinetics of the β2-adrenoceptor agonist, tulobuterol, in Beagle dogs following transdermal and intravenous administration. / Kim, J. H.; Kim, T. H.; Park, H. J.; Choi, Y. J.; Kang, J. H.; Song, K. H.; Koo, T. S.; Seo, Kyoung Won.

In: Veterinary Journal, Vol. 208, 01.02.2016, p. 90-92.

Research output: Contribution to journalArticle

Kim, J. H. ; Kim, T. H. ; Park, H. J. ; Choi, Y. J. ; Kang, J. H. ; Song, K. H. ; Koo, T. S. ; Seo, Kyoung Won. / The pharmacokinetics of the β2-adrenoceptor agonist, tulobuterol, in Beagle dogs following transdermal and intravenous administration. In: Veterinary Journal. 2016 ; Vol. 208. pp. 90-92.
@article{c88162299bd54c2db2032464f26fdde2,
title = "The pharmacokinetics of the β2-adrenoceptor agonist, tulobuterol, in Beagle dogs following transdermal and intravenous administration",
abstract = "Tulobuterol is a β2-adrenergic agonist that was the first bronchodilator approved as a transdermal patch for humans. Previous studies have examined the pharmacokinetics of tulobuterol in humans but not in the veterinary species. In this study, the pharmacokinetics of tulobuterol was examined in healthy Beagle dogs after transdermal and intravenous administration. The Cmax was 2.09 ng/mL at 16.0 h for a 0.2 mg/kg patch and 4.85 ng/mL at 13.6 h for a 0.4 mg/kg patch. The effective blood level in humans is 1-3 ng/mL, a concentration achieved using the 0.2 mg/kg patch in dogs. In conclusion, application of a 0.2 mg/kg tulobuterol patch to healthy dogs led to an apparently effective blood concentration for 24 h.",
keywords = "Canine, Pharmacokinetics, Transdermal patch, Tulobuterol, β-adrenoceptor agonist",
author = "Kim, {J. H.} and Kim, {T. H.} and Park, {H. J.} and Choi, {Y. J.} and Kang, {J. H.} and Song, {K. H.} and Koo, {T. S.} and Seo, {Kyoung Won}",
year = "2016",
month = "2",
day = "1",
doi = "10.1016/j.tvjl.2015.10.012",
language = "English (US)",
volume = "208",
pages = "90--92",
journal = "Veterinary Journal",
issn = "1090-0233",
publisher = "Bailliere Tindall Ltd",

}

TY - JOUR

T1 - The pharmacokinetics of the β2-adrenoceptor agonist, tulobuterol, in Beagle dogs following transdermal and intravenous administration

AU - Kim, J. H.

AU - Kim, T. H.

AU - Park, H. J.

AU - Choi, Y. J.

AU - Kang, J. H.

AU - Song, K. H.

AU - Koo, T. S.

AU - Seo, Kyoung Won

PY - 2016/2/1

Y1 - 2016/2/1

N2 - Tulobuterol is a β2-adrenergic agonist that was the first bronchodilator approved as a transdermal patch for humans. Previous studies have examined the pharmacokinetics of tulobuterol in humans but not in the veterinary species. In this study, the pharmacokinetics of tulobuterol was examined in healthy Beagle dogs after transdermal and intravenous administration. The Cmax was 2.09 ng/mL at 16.0 h for a 0.2 mg/kg patch and 4.85 ng/mL at 13.6 h for a 0.4 mg/kg patch. The effective blood level in humans is 1-3 ng/mL, a concentration achieved using the 0.2 mg/kg patch in dogs. In conclusion, application of a 0.2 mg/kg tulobuterol patch to healthy dogs led to an apparently effective blood concentration for 24 h.

AB - Tulobuterol is a β2-adrenergic agonist that was the first bronchodilator approved as a transdermal patch for humans. Previous studies have examined the pharmacokinetics of tulobuterol in humans but not in the veterinary species. In this study, the pharmacokinetics of tulobuterol was examined in healthy Beagle dogs after transdermal and intravenous administration. The Cmax was 2.09 ng/mL at 16.0 h for a 0.2 mg/kg patch and 4.85 ng/mL at 13.6 h for a 0.4 mg/kg patch. The effective blood level in humans is 1-3 ng/mL, a concentration achieved using the 0.2 mg/kg patch in dogs. In conclusion, application of a 0.2 mg/kg tulobuterol patch to healthy dogs led to an apparently effective blood concentration for 24 h.

KW - Canine

KW - Pharmacokinetics

KW - Transdermal patch

KW - Tulobuterol

KW - β-adrenoceptor agonist

UR - http://www.scopus.com/inward/record.url?scp=84957799797&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84957799797&partnerID=8YFLogxK

U2 - 10.1016/j.tvjl.2015.10.012

DO - 10.1016/j.tvjl.2015.10.012

M3 - Article

C2 - 26639828

AN - SCOPUS:84957799797

VL - 208

SP - 90

EP - 92

JO - Veterinary Journal

JF - Veterinary Journal

SN - 1090-0233

ER -